Stocks · Korea
002210
KOSPI
Dongsung Pharmaceutical
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
Returns and 52-week range
1W+2.62%
1M-8.82%
3M-33.56%
6M-33.56%
1Y-33.56%
YTD-33.56%
52W high2,525원
52W low1,116원
From 52W high-48.79%
Financial results (separate)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2022 | 933억 | -31억 | -21억 | -3.3% |
| 2023 | 886억 | 6억 | -21억 | 0.7% |
| 2024 | 884억 | -57억 | -146억 | -6.5% |
| 2025 | 872억 | -101억 | -257억 | -11.6% |
| Quarterly | ||||
| 2024 4Q | 226억 | -31억 | -119억 | -13.9% |
| 2025 1Q | 263억 | 7억 | -13억 | 2.8% |
| 2025 2Q | 200억 | -42억 | -188억 | -20.8% |
| 2025 3Q | 218억 | 4억 | 1억 | 1.9% |
| 2025 4Q | 191억 | -71억 | -58억 | -37.3% |
| 2026 1Q | 191억 | 3억 | 14,016,095원 | 1.5% |
Company
Address: 서울특별시 도봉구 도봉로 683 (방학동) 동성빌딩
Peers in the same sector
Recent filings
- 2026-08-18[기재정정]반기보고서 (2026.06)
- 2026-08-14반기보고서 (2026.06)
- 2026-05-15분기보고서 (2026.03)
- 2026-05-14[기재정정]주요사항보고서(감자결정) Major
- 2026-05-13[기재정정]주요사항보고서(감자결정) Major
- 2026-05-06[기재정정]사업보고서 (2025.12)
- 2026-05-06[기재정정]사업보고서 (2024.12)
- 2026-05-06[기재정정]사업보고서 (2023.12)
- 2026-04-29[기재정정]주요사항보고서(감자결정) Major
- 2026-04-24[기재정정]주요사항보고서(감자결정) Major
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.